Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting
Oncology Today with Dr Neil Love
00:00
Implications of relapse on subsequent options
Tam contrasts losing BTKi after continuous use versus the ability to re-challenge with venetoclax after fixed-duration therapy.
Play episode from 17:30
Transcript
